Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.
Professor and Chair, Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center
These findings are an example of the power of genomic sequencing and bioinformatic analysis - with a…
Associate Cancer Center Director, Yale Cancer Center Professor of Medicine, Yale School of Medicine New Haven, CT 06520
Dr Bob Comis was a stolid and long-term leader of the old cooperative group system. He helped lead …
Director WVU Cancer Institute Director of Cancer Signature Program Laurence S. and Jean J. DeLynn Chair of Oncology
This is a very interesting study that opens the door to prospective investigation of a randomized tr…
Executive Director Community Oncology Alliance
Another company making the right move to control drug prices, especially in cancer. In community onc…
National Health Policy Expert
The developers of Value Metric Frameworks continue to struggle to make them relevant and also to mak…
Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA; CEO, Global Resource for Advancing Cancer Education (GRACE)
In the feeding frenzy that is the business world's hype-driven interpretation of immunotherapy data,…
President, W-Squared Group
Definitely a very volatile topic. PBMs control a good part of the prescription claims process, but …
Managing Director and Senior Biotechnology Analyst
I am excited to be joining the editorial board on OBR; I have been a fan of the publication since it…
Chief Medical Officer and Founder, N-of-One
No comments to show!
Professor and Director, Division of Hematology Oncology Department of Medicine,Cedars-Sinai Medical Center Associate Director for Academic Program Development Samuel Oschin Comprehensive Cancer Institute Professor of Medicine and Urology, Emeritus David Geffen School of Medicine at UCLA
This long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …
FACP FACPE FASCO President, Minnesota Oncology
Watch closely as Amazon may seek to break traditional distribution models in the drug prescibing spa…
CEO Tennessee Oncology
Good for Genentech! The abuse of this program needs to end ASAP. I agree with the author and hope …
Vice President Integrated Community Oncology Network Former Community Representative ASCO Board of Directors
I have been and on again and off again reader of the Economist for a long time. This article rem…
Florida Cancer Specialists President and Managing Partner
At Florida Cancer Specialists we have been using DigniCap for several months at 3 of our site and it…
